<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-A0JHLXSV/51b94c61-e202-406c-b1e3-fc5810c27b12/PDF"><dcterms:extent>284 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-A0JHLXSV/f281a30a-4769-4d63-b7a6-138956a7d4c8/TEXT"><dcterms:extent>18 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="2008-2025"><edm:begin xml:lang="en">2008</edm:begin><edm:end xml:lang="en">2025</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:doc-A0JHLXSV"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/URN:NBN:SI:spr-YR600LYC" /><dcterms:issued>2012</dcterms:issued><dc:creator>Pevec, Teodor</dc:creator><dc:format xml:lang="sl">številka:1</dc:format><dc:format xml:lang="sl">letnik:5</dc:format><dc:format xml:lang="sl">str. 32-38</dc:format><dc:identifier>ISSN:1855-5640</dc:identifier><dc:identifier>COBISSID:512188984</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-A0JHLXSV</dc:identifier><dc:language>en</dc:language><dc:publisher xml:lang="sl">Medicinska fakulteta</dc:publisher><dcterms:isPartOf xml:lang="sl">Acta medico-biotechnica</dcterms:isPartOf><dc:subject xml:lang="en">hip fracture</dc:subject><dc:subject xml:lang="en">infection</dc:subject><dc:subject xml:lang="sl">kolčni sklep</dc:subject><dc:subject xml:lang="sl">sinbiotiki</dc:subject><dc:subject xml:lang="en">symbiotic</dc:subject><dc:subject xml:lang="en">Synbiotic</dc:subject><dc:subject xml:lang="en">therapy</dc:subject><dc:subject xml:lang="sl">vnetja</dc:subject><dc:subject xml:lang="sl">zdravljenje</dc:subject><dc:subject xml:lang="sl">zlomi</dc:subject><dcterms:temporal rdf:resource="2008-2025" /><dc:title xml:lang="sl">Vloga sinbiotikov v zmanjšanju okužb po operacijah zloma v predelu kolčnega sklepa| pilot study| pilotska študija| Role of synbiotics in reducing postoperative infections in patients with hip fracture|</dc:title><dc:description xml:lang="sl">Purpose: Despite the development of surgical methods, infections continue to be serious postoperative complications. Probiotics have been shown to be effective in reducing the prevalence of infections. We explored the effectiveness of probiotics in reducing the prevalence of infections in subjects undergoing surgery for hip fractures. Methods: Fifty-one patients admitted for surgical treatment of hip fractures were divided randomly into two groups: Synbiotic 2000 Forte and placebo. The occurrence of infection was closely observed upon hospital admission until the fifth postoperative day using, among other parameters, the C-reactive protein (CRP) level. Additionally, the patients' tolerance to Synbiotic 2000 Forte was established using subjective (self-reported problems) and objective means. Results: Infection was confirmed in 4 patients in each group. Urinary tract infection was noted in 7 subjects and a local wound infection in 1 patient. No differences were found in CRP levels upon hospital admission and the fifth postoperative day. Tolerance to Synbiotic 2000 Forte was lower in patients undergoing placebo treatment. Conclusion: Synbiotic 2000 Forte did not reduce the number of postoperative infections. Further studies are needed to confirm these findings</dc:description><dc:description xml:lang="sl">Namen: Število bolnikov z zlomom v predelu kolčnega sklepa narašča skupaj s staranjem prebivalstva. Okužbe, ki nastopajo po samem posegu, tako sistemske kot lokalne, pomembno vplivajo na uspeh operacije. Uporaba probiotikov dokazano zmanjšuje okužbe, zato nas zanima, ali lahko uporaba le-teh zmanjšuj eokužbe tudi v skupini bolnikov po operacijah zlomov v predelu kolčnega sklepa. Metode: Opravili smo dvojno slepo randomizirano študijo pri51 bolnikih. Ob sprejemu so dobili ali preparat SYNBIOTIK 2000 FORTE ali placebo. Opazovali smo nastanek okužb, merili vrednost C reaktivnega proteinain opazovali, kako so bolniki prenašali uživanje preparata. Rezultati: Okužbe so se pojavile prištirih bolnikih v vsaki skupini. Pri sedmih bolnikih je šlo za uroinfekt in pri enem za okužbo rane Zaključek: V raziskavi nismo dokazali vpliva SYNBIOTICA 2000 FORTE na zmanjševanje okužb pooperacijah zlomov v predelu kolčnega sklepa. Število bolnikov bi moralo bitivečje, skupina bi morala biti manj heterogena glede na stopnjo ogroženosti bolnikov pred operacijo in na čas med poškodbo in operacijo</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:doc-A0JHLXSV"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:doc-A0JHLXSV" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:doc-A0JHLXSV/51b94c61-e202-406c-b1e3-fc5810c27b12/PDF" /><edm:rights rdf:resource="http://creativecommons.org/licenses/by/4.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Univerza v Mariboru, Medicinska fakulteta</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:doc-A0JHLXSV/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:doc-A0JHLXSV" /></ore:Aggregation></rdf:RDF>